BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 34426758)

  • 1. Mitoquinone Protects Podocytes from Angiotensin II-Induced Mitochondrial Dysfunction and Injury via the Keap1-Nrf2 Signaling Pathway.
    Zhu Z; Liang W; Chen Z; Hu J; Feng J; Cao Y; Ma Y; Ding G
    Oxid Med Cell Longev; 2021; 2021():1394486. PubMed ID: 34426758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of SETD6 protects podocyte against high glucose and palmitic acid-induced apoptosis, and mitochondrial dysfunction via activating Nrf2-Keap1 signaling pathway in diabetic nephropathy.
    Wang X; Liu Q; Kong D; Long Z; Guo Y; Wang S; Liu R; Hai C
    J Mol Histol; 2020 Oct; 51(5):549-558. PubMed ID: 32803470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mitochondria-targeted antioxidant MitoQ ameliorated tubular injury mediated by mitophagy in diabetic kidney disease via Nrf2/PINK1.
    Xiao L; Xu X; Zhang F; Wang M; Xu Y; Tang D; Wang J; Qin Y; Liu Y; Tang C; He L; Greka A; Zhou Z; Liu F; Dong Z; Sun L
    Redox Biol; 2017 Apr; 11():297-311. PubMed ID: 28033563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astragaloside IV attenuates podocyte apoptosis through ameliorating mitochondrial dysfunction by up-regulated Nrf2-ARE/TFAM signaling in diabetic kidney disease.
    Shen Q; Fang J; Guo H; Su X; Zhu B; Yao X; Wang Y; Cao A; Wang H; Wang L
    Free Radic Biol Med; 2023 Jul; 203():45-57. PubMed ID: 37030337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MitoQ ameliorates testis injury from oxidative attack by repairing mitochondria and promoting the Keap1-Nrf2 pathway.
    Zhang J; Bao X; Zhang M; Zhu Z; Zhou L; Chen Q; Zhang Q; Ma B
    Toxicol Appl Pharmacol; 2019 May; 370():78-92. PubMed ID: 30836114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MitoQ protects against high glucose-induced brain microvascular endothelial cells injury via the Nrf2/HO-1 pathway.
    Yang MY; Fan Z; Zhang Z; Fan J
    J Pharmacol Sci; 2021 Jan; 145(1):105-114. PubMed ID: 33357768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitophagy Reduces Oxidative Stress Via Keap1 (Kelch-Like Epichlorohydrin-Associated Protein 1)/Nrf2 (Nuclear Factor-E2-Related Factor 2)/PHB2 (Prohibitin 2) Pathway After Subarachnoid Hemorrhage in Rats.
    Zhang T; Wu P; Budbazar E; Zhu Q; Sun C; Mo J; Peng J; Gospodarev V; Tang J; Shi H; Zhang JH
    Stroke; 2019 Apr; 50(4):978-988. PubMed ID: 30890112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitoquinone attenuates vascular calcification by suppressing oxidative stress and reducing apoptosis of vascular smooth muscle cells via the Keap1/Nrf2 pathway.
    Cui L; Zhou Q; Zheng X; Sun B; Zhao S
    Free Radic Biol Med; 2020 Dec; 161():23-31. PubMed ID: 33011276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of USP15 ameliorates high-glucose-induced oxidative stress and inflammatory injury in podocytes through regulation of the Keap1/Nrf2 signaling.
    Xu E; Yin C; Yi X; Liu Y
    Environ Toxicol; 2022 Apr; 37(4):765-775. PubMed ID: 34931430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirt6 deficiency contributes to mitochondrial fission and oxidative damage in podocytes via ROCK1-Drp1 signalling pathway.
    Chen Z; Liang W; Hu J; Zhu Z; Feng J; Ma Y; Yang Q; Ding G
    Cell Prolif; 2022 Oct; 55(10):e13296. PubMed ID: 35842903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydrotanshinone I inhibits gallbladder cancer growth by targeting the Keap1-Nrf2 signaling pathway and Nrf2 phosphorylation.
    Li Z; Mo RL; Gong JF; Han L; Wang WF; Huang DK; Xu JG; Sun YJ; Chen S; Han GC; Sun DQ
    Phytomedicine; 2024 Jul; 129():155661. PubMed ID: 38677269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sirt6-mediated Nrf2/HO-1 activation alleviates angiotensin II-induced DNA DSBs and apoptosis in podocytes.
    Fan Y; Cheng J; Yang Q; Feng J; Hu J; Ren Z; Yang H; Yang D; Ding G
    Food Funct; 2021 Sep; 12(17):7867-7882. PubMed ID: 34240732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRD4 contributes to high-glucose-induced podocyte injury by modulating Keap1/Nrf2/ARE signaling.
    Zuo H; Wang S; Feng J; Liu X
    Biochimie; 2019 Oct; 165():100-107. PubMed ID: 31325480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mitochondrially targeted antioxidant MitoQ protects the intestinal barrier by ameliorating mitochondrial DNA damage via the Nrf2/ARE signaling pathway.
    Hu Q; Ren J; Li G; Wu J; Wu X; Wang G; Gu G; Ren H; Hong Z; Li J
    Cell Death Dis; 2018 Mar; 9(3):403. PubMed ID: 29540694
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Hu X; Mu L; Zhu L; Chang X; Nie L; Wang L; Li G
    Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sesn2 attenuates the damage of endothelial progenitor cells induced by angiotensin II through regulating the Keap1/Nrf2 signal pathway.
    Ding S; Ma N; Liu H; Tang M; Mei J
    Aging (Albany NY); 2020 Nov; 12(24):25505-25527. PubMed ID: 33231566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atg7- and Keap1-dependent autophagy protects breast cancer cell lines against mitoquinone-induced oxidative stress.
    Gonzalez Y; Aryal B; Chehab L; Rao VA
    Oncotarget; 2014 Mar; 5(6):1526-37. PubMed ID: 24681637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perilipin 5 ameliorates high-glucose-induced podocyte injury via Akt/GSK-3β/Nrf2-mediated suppression of apoptosis, oxidative stress, and inflammation.
    Feng J; Xie L; Yu X; Liu C; Dong H; Lu W; Kong R
    Biochem Biophys Res Commun; 2021 Mar; 544():22-30. PubMed ID: 33516878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulforaphane attenuates angiotensin II-induced human umbilical vein endothelial cell injury by modulating ROS-mediated mitochondrial signaling.
    Zhang M; Xu Y; Jiang L
    Hum Exp Toxicol; 2020 May; 39(5):734-747. PubMed ID: 31957488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of klotho on palmitate-induced podocyte injury in diabetic nephropathy.
    Suk Kang J; Son SS; Lee JH; Lee SW; Jeong AR; Lee ES; Cha SK; Chung CH; Lee EY
    PLoS One; 2021; 16(4):e0250666. PubMed ID: 33891667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.